Self-discharge is a normally occurring phenomenon in lithium-ion battery cells. A normal cell may have a self-discharge rate of 1% state of charge (SOC) per month. The normal self-discharge rate is ...

Rumors about the astonishing weight loss potential of Eli Lilly's triple hormone drug retatrutide have been circulating for months. The results of its Phase 3 clinical trial, just released by the ...

This readme.md is based upon the HX711 readme.md, so it may contain some sections that are not updated yet. This HX712 library has a public interface (API) which is based upon my HX711 library which ...

Abstract: Animal laboratory experiments have important role in the development of specialist science related to health, biology, and pharmacy. To carry out the trial of medicines, the researchers ...

WeightWatchers' Core+ program offers personalized weight loss support starting at $20 per month. The program focuses on nutrition, habit-building and community support. Core+ features specialized ...

Bariatric surgery far outperformed GLP-1 weight loss drugs in a new real-world comparison of more than 50,000 patients. Two years after treatment, surgery patients lost about 58 pounds on average, ...

Even after weight loss, CD4 T cells may retain an obesity-linked inflammatory memory, revealing why immune recovery may lag behind metabolic improvement. Study: DNA methylation-mediated memory of ...

For months, readers emailed Snopes and searched our website asking whether well-known public figures were really endorsing a gelatin — often specifically "pink gelatin" — trick for weight loss. The ...

Chocolate bars made from lab-grown ingredients, rather than cocoa sourced from plantations, are no longer confined to science fiction. They are now a reality, with nearly a dozen such chocolate bars ...

Weight-based pembrolizumab dosing demonstrated comparable effectiveness and safety to fixed dosing in patients with advanced non-small cell lung cancer (NSCLC). In a real-world cohort of 414 patients, ...

We conducted a retrospective cohort study of 414 patients with advanced NSCLC treated with pembrolizumab at a single center between 2016 and 2021. Patients received either fixed-dose or weight-based ...

Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and ...